Literature DB >> 24235063

The association between hypertensive disorders in pregnancy and bronchopulmonary dysplasia: a systematic review.

Guang-Liang Bi1, Fei-Li Chen, Wei-Min Huang.   

Abstract

BACKGROUND: Whether hypertensive disorders in pregnancy (HDP) are the risk factors of bronchopulmonary dysplasia (BPD) is controversial. A systematic review was made to determine the association between HDP and BPD in preterm infants.
METHODS: We searched PubMed, Embase, Cochrane Library, ScienceDirect, Web of Science, with no language limitation, and reviewed the reference lists of the selected articles to identify additional relevant publications and contacted the authors of relevant studies for further information. The data were extracted independently by 2 reviewers who used a predetermined data extraction form. Studies were combined with an odds ratio (OR) using a random-effects model. Meta-regression and subgroup analysis were used to explore potential confounders. Funnel plots, Egger's test and Begg's test were used to investigate the publication bias. The Trim and Fill method was used to control the publication bias.
RESULTS: A total of 787 studies were identified and only 15 studies (20 779 patients) were included. The pooled unadjusted OR showed that HDP was significantly associated with BPD (P=0.04; OR=1.29, 95% CI=1.01-1.65). Heterogeneity was substantial (I(2)=74%) and might be partially explained by different variables in maternal complications between the control groups across the studies. The pooled adjusted OR suggested the same conclusion that HDP was a risk factor for BPD (P=0.01; OR=1.59, 95% CI=1.11-2.26). Funnel plot and Egger's test showed that there were publication bias of unadjusted estimate of association between HDP and BPD.
CONCLUSIONS: Unadjusted analyses showed that the rate of BPD was slightly higher in the infants exposed to HDP, and adjusted analyses confirmed this finding. But this result should be interpreted cautiously because substantial heterogeneity and publication bias were identified in this review.

Entities:  

Mesh:

Year:  2013        PMID: 24235063     DOI: 10.1007/s12519-013-0439-8

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  34 in total

1.  Rates of bronchopulmonary dysplasia in very preterm neonates in Europe: results from the MOSAIC cohort.

Authors:  Ludwig Gortner; Björn Misselwitz; David Milligan; Jennifer Zeitlin; Louis Kollée; Klaus Boerch; Rocco Agostino; Patrick Van Reempts; Jean-Louis Chabernaud; Gérard Bréart; Emile Papiernik; Pierre-Henri Jarreau; Manuel Carrapato; Janusz Gadzinowski; Elizabeth Draper
Journal:  Neonatology       Date:  2010-08-23       Impact factor: 4.035

Review 2.  Definitions and diagnostic criteria for bronchopulmonary dysplasia.

Authors:  Eduardo Bancalari; Nelson Claure
Journal:  Semin Perinatol       Date:  2006-08       Impact factor: 3.300

3.  Maternal preeclampsia predicts the development of bronchopulmonary dysplasia.

Authors:  Anne R Hansen; Carmen M Barnés; Judah Folkman; Thomas F McElrath
Journal:  J Pediatr       Date:  2009-12-14       Impact factor: 4.406

4.  Neonatal outcomes of premature infants born to preeclamptic mothers.

Authors:  Merih Cetinkaya; Hilal Ozkan; Nilgün Köksal; Zuhal Karali; Taner Ozgür
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05

5.  Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants.

Authors:  Raymond W Redline; Deanne Wilson-Costello; Maureen Hack
Journal:  Pediatr Res       Date:  2002-11       Impact factor: 3.756

6.  Bronchopulmonary dysplasia: clinical presentation.

Authors:  E Bancalari; G E Abdenour; R Feller; J Gannon
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

7.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

8.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

Authors:  M Jakkula; T D Le Cras; S Gebb; K P Hirth; R M Tuder; N F Voelkel; S H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-09       Impact factor: 5.464

9.  Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy.

Authors:  L Weinstein
Journal:  Am J Obstet Gynecol       Date:  1982-01-15       Impact factor: 8.661

10.  Effect of early postnatal neutropenia in very low birth weight infants born to mothers with pregnancy-induced hypertension.

Authors:  Yang Hee Park; Gyung Min Lee; Jung Min Yoon; Enn Jung Cheon; Kyung Ok Ko; Yung Hyuk Lee; Jae Woo Lim
Journal:  Korean J Pediatr       Date:  2012-12-20
View more
  4 in total

1.  Association of Maternal Hypertensive Disorders During Pregnancy With Severe Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis.

Authors:  Gina Lim; Yoo Jinie Kim; Sochung Chung; Yong Mean Park; Kyo Sun Kim; Hye Won Park
Journal:  J Korean Med Sci       Date:  2022-04-25       Impact factor: 5.354

2.  Molecular mechanism of miR-181b in heart disease due to pregnancy-induced hypertension syndrome.

Authors:  Zheng Gao; Li Wang; Jinyun Wang; Fengyong Yang; Jin Qu
Journal:  Exp Ther Med       Date:  2017-08-03       Impact factor: 2.447

3.  The significance of combined detection of CysC, urinary mAlb and β2-MG in diagnosis of the early renal injury in pregnancy-induced hypertension syndrome.

Authors:  Lin Zhang; Jin Sun; Ming Zhang; Yun Lin; Le Fang; Xing Fang; Weitu Mai; Zhiping Yin
Journal:  Saudi J Biol Sci       Date:  2019-08-01       Impact factor: 4.219

4.  Association of the dysfunctional placentation endotype of prematurity with bronchopulmonary dysplasia: a systematic review, meta-analysis and meta-regression.

Authors:  Maria Pierro; Eduardo Villamor-Martinez; Elke van Westering-Kroon; Maria Alvarez-Fuente; Steven H Abman; Eduardo Villamor
Journal:  Thorax       Date:  2021-07-23       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.